Hanninen, Mikael, Peter Venner, and Scott North. 2013. “A Rapid PSA Half-Life Following Docetaxel Chemotherapy Is Associated With Improved Survival in Hormone Refractory Prostate Cancer”. Canadian Urological Association Journal 3 (5):369-74. https://doi.org/10.5489/cuaj.1145.